The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-2-cyano-3-(furan-3-yl)-N-phenylacrylamide ID: ALA4064100
Chembl Id: CHEMBL4064100
PubChem CID: 137635127
Max Phase: Preclinical
Molecular Formula: C14H10N2O2
Molecular Weight: 238.25
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: N#C/C(=C\c1ccoc1)C(=O)Nc1ccccc1
Standard InChI: InChI=1S/C14H10N2O2/c15-9-12(8-11-6-7-18-10-11)14(17)16-13-4-2-1-3-5-13/h1-8,10H,(H,16,17)/b12-8+
Standard InChI Key: OIOFMTRDIKWIRW-XYOKQWHBSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 238.25Molecular Weight (Monoisotopic): 238.0742AlogP: 2.83#Rotatable Bonds: 3Polar Surface Area: 66.03Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.06CX Basic pKa: ┄CX LogP: 2.52CX LogD: 2.52Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.66Np Likeness Score: -0.91
References 1. Vivier D, Soussia IB, Rodrigues N, Lolignier S, Devilliers M, Chatelain FC, Prival L, Chapuy E, Bourdier G, Bennis K, Lesage F, Eschalier A, Busserolles J, Ducki S.. (2017) Development of the First Two-Pore Domain Potassium Channel TWIK-Related K+ Channel 1-Selective Agonist Possessing in Vivo Antinociceptive Activity., 60 (3): [PMID:28051863 ] [10.1021/acs.jmedchem.6b01285 ]